Selective immunosuppressants

APO MYC500 Pill - purple capsule-shape, 16mm

Pill with imprint APO MYC500 is Purple, Capsule-shape and has been identified as Mycophenolate Mofetil 500 mg. It is supplied by Apotex Corp.

Mycophenolate mofetil is used in the treatment of Nephrotic Syndrome; Organ Transplant, Rejection Prophylaxis; Graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Mycophenolate mofetil (oral/injection) (Mycophenolate mofetil (oral/injection) [ mye-koe-fen-oh-late-moe-fe-til ])-APO MYC500-500 mg-Purple-Capsule-shape
Mycophenolate mofetil (oral/injection) (Mycophenolate mofetil (oral/injection) [ mye-koe-fen-oh-late-moe-fe-til ])-APO MYC500-500 mg-Purple-Capsule-shape

Mycophenolate mofetil (oral/injection)
Generic Name: mycophenolate mofetil (oral/injection) [ mye-koe-fen-oh-late-moe-fe-til ]
Imprint: APO MYC500
Strength: 500 mg
Color: Purple
Size: 16.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Selective immunosuppressants
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Croscarmellose sodium, Magnesium stearate, Ferric oxide red, Titanium dioxide, Ferrosoferric oxide, Microcrystalline cellulose, Silicon dioxide, Hypromelloses, Hydroxypropyl cellulose, Propylene glycol,
Latest News
Related Drugs